PCR Technologies Market Analysis and Forecast to 2031: By Product (Reagents and Consumables, Instruments, and Others), Technology (Real-Time PCR, Traditional PCR, Digital PCR, and Others), End-User (Diagnostic Centers and Hospitals, Biotech and Pharma Companies, Academic and Research Institutions, and Others), and Region

PCR (Polymerase Chain Reaction) is a powerful technique used to amplify small pieces of DNA. The PCR process can be used to create multiple copies of a specific DNA sequence, allowing researchers to study a particular gene or region of the genome in greater detail. PCR can also be used to detect the presence of a specific DNA sequence in a sample, making it a valuable tool for diagnosing genetic diseases.

Key Trends

The key trends in PCR Technologies technology are miniaturization, portability, and automation. Miniaturization refers to the ability to perform PCR reactions in smaller volumes, which is made possible by the use of smaller reaction vessels and smaller amounts of reagents. This trend has been driven by the need for more sensitive and specific detection of target nucleic acids, as well as the desire to reduce costs. Portability refers to the ability to perform PCR reactions without the need for a dedicated laboratory or expensive equipment. This is made possible by the use of portable PCR devices that can be used in a variety of settings, including field settings. Automation refers to the ability to perform PCR reactions with minimal human intervention. This is made possible by the use of automated PCR devices that can perform the entire reaction, from template preparation to product detection, without the need for manual intervention.

Key Drivers

PCR technologies are used in a wide range of applications in the field of molecular diagnostics, including cancer, infectious diseases, and genetic disorders. The key drivers of the PCR technologies market are the increasing incidence of cancer and the rising prevalence of genetic disorders. In addition, the increasing demand for point-of-care testing and the development of new PCR-based assays are expected to drive the growth of the PCR technologies market.

Restraints & Challenges

The main restraints on the PCR technologies market are the high cost of the technology and the lack of standardization. The high cost of the technology is a result of the need for specialized equipment and reagents, as well as the trained personnel required to operate it. The lack of standardization is a result of the many different PCR technologies that have been developed, each with its own advantages and disadvantages. This has led to a situation where there is no one “best” PCR technology, and different laboratories often use different technologies depending on their particular needs.

Key Market Segments

The PCR technologies market report is bifurcated on the basis of product, technology, end-user, and region. On the basis of product, it is segmented into reagents & consumables, instruments, and others. Based on technology, it is analyzed across real-time PCR, traditional PCR, digital PCR, and others. By end-user is it spread across diagnostic centers & hospitals, biotech & pharma companies, academic & research institutions, and others. Region-wise, it is studied across North America, Europe, Asia-Pacific, and rest of the World.

Key Market Players

The PCR technologies market report includes players such as Bio-Rad Laboratories, Inc., QIAGEN N.V., Takara Bio, Inc., Agilent Technologies, Inc., bioMérieux S.A., Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, and Eppendorf AG.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. PCR Technologies Market Outlook
3.1. PCR Technologies Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Global PCR Technologies Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Global PCR Technologies Market
4.3. Economic Impact Analysis

Chapter 5. PCR Technologies Market by Product
5.1. Market Overview
5.2. Reagents & Consumables
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Instruments
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. Others
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. PCR Technologies Market by Technology
6.1. Market Overview
6.2. Real-Time PCR
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Traditional PCR
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Digital PCR
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.5. Others
6.5.1. Market Size and Forecast, 2021-2031 ($Million)
6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. PCR Technologies Market by End-User
7.1. Market Overview
7.2. Diagnostic Centers & Hospitals
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Biotech & Pharma Companies
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Academic & Research Institutions
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. PCR Technologies Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.3. North America PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.4. North America PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.2.5. North America PCR Technologies Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.6.2. The U.S. PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.6.3. The U.S. PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.7.2. Canada PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.7.3. Canada PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.8.2. Mexico PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.8.3. Mexico PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.3. Europe PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.4. Europe PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.5. Europe PCR Technologies Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.6.2. Germany PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.6.3. Germany PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.7.2. France PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.7.3. France PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.8.2. U.K. PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.8.3. U.K. PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.9.2. Spain PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.9.3. Spain PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.10.2. Italy PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.10.3. Italy PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.11.2. Rest of Europe PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.11.3. Rest of Europe PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific PCR Technologies Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.4. Asia-Pacific PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.5. Asia-Pacific PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.6.2. China PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.6.3. China PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.7.2. India PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.7.3. India PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.8.2. Japan PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.8.3. Japan PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.9.2. South Korea PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.9.3. South Korea PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.10.2. Rest of APAC PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.10.3. Rest of APAC PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.3. Rest of the World PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.4. Rest of the World PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5.5. Rest of the World PCR Technologies Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.6.2. Latin America PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.6.3. Latin America PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.7.2. Middle East PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.7.3. Middle East PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa PCR Technologies Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.8.2. Africa PCR Technologies Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.8.3. Africa PCR Technologies Market Size and Forecast by End-User, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Bio-Rad Laboratories, Inc.
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. QIAGEN N.V.
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Takara Bio, Inc.
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Agilent Technologies, Inc
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. bioMérieux S.A.
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Fluidigm Corporation
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Danaher Corporation
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Abbott Laboratories
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Merck KGaA
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Eppendorf AG
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report
Key Market Players
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Takara Bio, Inc.
  • Agilent Technologies, Inc.
  • bioMérieux S.A.
  • Fluidigm Corporation
  • Danaher Corporation
  • Abbott Laboratories
  • Merck KGaA
  • Eppendorf AG
Key Market Segments

By Product

  • Reagents & Consumables
  • Instruments
  • Others

By Technology

  • Real-Time PCR
  • Traditional PCR
  • Digital PCR
  • Others

By End-User

  • Diagnostic Centers & Hospitals
  • Biotech & Pharma Companies
  • Academic & Research Institutions
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • The Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

 

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Entertainment Robots are robots that are designed for…
The Micro Carbon Residue Tester is a device…
Tactical Data Link (TDL) is a communications system…
IoT technology refers to the interconnectedness of physical…
Neuromorphic computing is a type of computing that…
Fiber optic components are devices that are used…
Precision farming is a management system for agricultural…
A defibrillator analyzer is a type of medical…
The global terahertz technology market was valued at…
Smart Home technology refers to a home that…